429 related articles for article (PubMed ID: 9703911)
21. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
[TBL] [Abstract][Full Text] [Related]
22. A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.
Bhargava P; Marshall JL; Dahut W; Rizvi N; Trocky N; Williams JI; Hait H; Song S; Holroyd KJ; Hawkins MJ
Clin Cancer Res; 2001 Dec; 7(12):3912-9. PubMed ID: 11751482
[TBL] [Abstract][Full Text] [Related]
23. [Modulation of the antitumor effect of cyclophosphamide by the recombinant probiotic Subalin].
Cherdyntseva NV; Litviakov NV; Smol'ianinov ES; Beliavskaia VA; Masycheva VI
Vopr Onkol; 1997; 43(3):313-6. PubMed ID: 9245089
[TBL] [Abstract][Full Text] [Related]
24. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy.
Emerman JT; Siemiatkowski J
Cancer Res; 1984 Apr; 44(4):1327-32. PubMed ID: 6704951
[TBL] [Abstract][Full Text] [Related]
25. MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma.
Teicher BA; Alvarez E; Liu P; Lu K; Menon K; Dempsey J; Schultz RM
Semin Oncol; 1999 Apr; 26(2 Suppl 6):55-62. PubMed ID: 10598556
[TBL] [Abstract][Full Text] [Related]
26. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
Zhang R; Tian L; Chen LJ; Xiao F; Hou JM; Zhao X; Li G; Yao B; Wen YJ; Li J; Zhang L; Chen XC; Luo F; Peng F; Jiang Y; Wei YQ
Gene Ther; 2006 Sep; 13(17):1263-71. PubMed ID: 16672984
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma.
Anderson IC; Shipp MA; Docherty AJ; Teicher BA
Cancer Res; 1996 Feb; 56(4):715-8. PubMed ID: 8631001
[TBL] [Abstract][Full Text] [Related]
28. A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models.
Emanuel S; Gruninger RH; Fuentes-Pesquera A; Connolly PJ; Seamon JA; Hazel S; Tominovich R; Hollister B; Napier C; D'Andrea MR; Reuman M; Bignan G; Tuman R; Johnson D; Moffatt D; Batchelor M; Foley A; O'Connell J; Allen R; Perry M; Jolliffe L; Middleton SA
Mol Pharmacol; 2004 Sep; 66(3):635-47. PubMed ID: 15322256
[TBL] [Abstract][Full Text] [Related]
29. [Combined low-dose chemotherapy inhibiting angiogenesis and growth of Lewis lung cancinoma xenografts in mice].
Qiu M; Yi C; Hou M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):534-7. PubMed ID: 16909595
[TBL] [Abstract][Full Text] [Related]
30. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
Latimer P; Menchaca M; Snyder RM; Yu W; Gilbert BE; Sanders BG; Kline K
Exp Biol Med (Maywood); 2009 Oct; 234(10):1244-52. PubMed ID: 19657067
[TBL] [Abstract][Full Text] [Related]
31. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
[TBL] [Abstract][Full Text] [Related]
32. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
[TBL] [Abstract][Full Text] [Related]
33. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
[TBL] [Abstract][Full Text] [Related]
34. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.
Teicher BA; Sotomayor EA; Huang ZD
Cancer Res; 1992 Dec; 52(23):6702-4. PubMed ID: 1384969
[TBL] [Abstract][Full Text] [Related]
35. The proteasome inhibitor PS-341 in cancer therapy.
Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J
Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643
[TBL] [Abstract][Full Text] [Related]
36. Prevention of local tumor growth with paclitaxel-loaded microspheres.
Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
[TBL] [Abstract][Full Text] [Related]
37. Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.
Datta A; Kitson RP; Xue Y; al-Atrash G; Mazar AP; Jones TR; Goldfarb RH
In Vivo; 2002; 16(6):451-7. PubMed ID: 12494889
[TBL] [Abstract][Full Text] [Related]
38. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of metastasis by cicaprost in rats with established SMT2A mammary carcinoma growth.
Schirner M; Schneider MR
Cancer Detect Prev; 1997; 21(1):44-50. PubMed ID: 9043762
[TBL] [Abstract][Full Text] [Related]
40. [Antitumor effects of recombinant quail vascular endothelial growth factor receptor 2, as a vaccine, combined with cisplatin on LL/2 tumor model in mice].
Hou JM; Liu JY; Yang L; Zhao X; Tian L; Lei S; Mao YQ; Wen YJ; Wei YQ
Ai Zheng; 2005 Apr; 24(4):391-6. PubMed ID: 15820058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]